Renato Lucca

Analista de laboratório Sênior at Onkos Molecular Diagnostics - Ribeirão Preto, São Paulo, Brazil

Renato Lucca's Colleagues at Onkos Molecular Diagnostics
Suzana Araujo

Analista de Laboratorio

Contact Suzana Araujo

Andrei Oliveira

Analista Pleno de Pesquisa e Desenvolvimento

Contact Andrei Oliveira

Raquel Santos

Líder de Atendimento, Logística e Laboratórios Parceiros

Contact Raquel Santos

Leonardo Joaquim

Analista de Produção de Conteúdo e Design

Contact Leonardo Joaquim

Mirela Prates

Analista de Laboratório Pleno

Contact Mirela Prates

Isabela Morales

Analista de pesquisa e desenvolvimento

Contact Isabela Morales

View All Renato Lucca's Colleagues
Renato Lucca's Contact Details
HQ
Location
Ribeirão Preto,São Paulo,Brazil
Company
Onkos Molecular Diagnostics
Renato Lucca's Company Details
Onkos Molecular Diagnostics logo, Onkos Molecular Diagnostics contact details

Onkos Molecular Diagnostics

Ribeirão Preto, São Paulo, Brazil • 19 Employees
Health, Wellness & Fitness

Onkos is Latin America´s leading startup company provider of proprietary gene expression-based diagnostic tests that is focused on providing answers to diagnostic uncertainties in Oncology by avoiding unnecessary procedures. We guide informed clinical decisions to enable not only the best patient management available but also healthcare providers efficiencies and savings. Our Gene Expression Profiling platform merges cutting-edge technologies of molecular biology and artificial intelligence tools to create molecular classifiers that are translated into actionable results to unlock the best care for cancer patients. Our current portfolio is composed of the two first gene expression-based tests developed and applied on clinical routine in the southern hemisphere: a. mir-THYpe®, which is a microRNA-based molecular classifier for thyroid nodules with indeterminate cytology. To date, we are driving a revolution with a dramatic reduction in unnecessary thyroid surgeries. The validation study showed a 96% NPV and the test is performed using the readily available smear slides already prepared for prior cytology test.b. TOT- Tumor Origin Test, which is an mRNA-based molecular classifier for Metastatic Cancers with Unknown Primary site. We are providing data that can help physicians with treatment decisions resulting in the patient's best care. The test evaluates the expression profiling generated by a panel of 95 genes and compares the genetic signatures with a database of 4400 known primary cancers, divided into 25 cancer types. We have licensed this test patent and commercialization rights to Fleury Group, one of the largest laboratory networks in Latin America.Onkos is part of the two main Healthcare Innovation Centers in Latin America:a. The Eretz.bio hub, which is linked to the main private hospital in Latin America – Albert Einstein Hospitalb. The SUPERA Technology Park, which is linked to the main university in Latin America – Univesity of São Paulo (USP)

Details about Onkos Molecular Diagnostics
Frequently Asked Questions about Renato Lucca
Renato Lucca currently works for Onkos Molecular Diagnostics.
Renato Lucca's role at Onkos Molecular Diagnostics is Analista de laboratório Sênior.
Renato Lucca's email address is ***@onkos.com.br. To view Renato Lucca's full email address, please signup to ConnectPlex.
Renato Lucca works in the Health, Wellness & Fitness industry.
Renato Lucca's colleagues at Onkos Molecular Diagnostics are Suzana Araujo, Andrei Oliveira, Raquel Santos, Leonardo Joaquim, Mirela Prates, Isabela Morales, Miriane Oliveira and others.
Renato Lucca's phone number is
See more information about Renato Lucca